Wenzelspine Series B2 Preferred Stock
January 2019 – England & Company served as the financial advisor to Wenzel Spine, Inc., in its Series B financing round.
WenzelSpine is a developer of advanced medical devices designed to offer treatment of spinal disorders. The company’s devices deliver surgical systems that improve the overall quality of spine care by simplifying procedures and reducing recovery time, enabling surgeons to improve the quality of their treatment and help their patients ensure a quick recovery.